期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

炎症性肠病的现代内科治疗 被引量：3

原文传递
导出
摘要 炎症性肠病（inflammatory bowel diseases，IBD）包括溃疡性结肠炎（ulcerative colffis，UC）、克罗恩病（Crohn’s disease，CD）和中间型结肠炎（intermediate colitis，IC），其发病机制仍不明确，可能与基因遗传、肠道免疫反应异常与环境等因素有关。
作者 钟英强 叶小研
机构地区 中山大学孙逸仙纪念医院消化内科
出处 《中华临床医师杂志（电子版）》 CAS 2013年第16期6-8,共3页 Chinese Journal of Clinicians(Electronic Edition)
关键词 炎症性肠病 内科治疗 DISEASES 溃疡性结肠炎 免疫反应异常 克罗恩病 发病机制 基因遗传
分类号 R574 [医药卫生—消化系统]
  • 相关文献

参考文献18

  • 1吴新环,钟英强.骨髓间质干细胞对炎症性肠病肠上皮重建的作用机制[J].胃肠病学,2012,17(4):245-247. 被引量：4
  • 2钟英强,林莹,昝慧.电子肠镜在炎症性肠病诊断、治疗和随访中的应用[J].中华临床医师杂志（电子版）,2011,5(4):8-11. 被引量：5
  • 3于海食,洪缨,王玉蓉.溃疡性结肠炎的中西药物治疗概况[J].世界华人消化杂志,2008,16(35):3979-3983. 被引量：14
  • 4Francis A. Farraye,Robert D. Odze,Jayne Eaden,Steven H. Itzkowitz.AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease[J].Gastroenterology.2010(2)
  • 5Charles N.Bernstein,MichaelFried,J.H.Krabshuis,HenryCohen,R.Eliakim,SuleimanFedail,RichardGearry,K.L.Goh,SaheedHamid,Aamir GhaforKhan,A.W.LeMair,Malfertheiner,QinOuyang,J.F.Rey,AjitSood,FlavioSteinwurz,Ole O.Thomsen,AlanThomson,GillianWatermeyer.World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010[J].Inflamm Bowel Dis.2009(1)
  • 6A.OUSSALAH,C.LACLOTTE,J.‐B.CHEVAUX,M.BENSENANE,A.BABOURI,A.‐A.SERRE,T.BOUCEKKINE,X.ROBLIN,M.‐A.BIGARD,L.PEYRIN‐BIROULET.Long‐term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single‐centre experience[J].Alimentary Pharmacology & Therapeutics.2008(8)
  • 7Mairi Brittan,Malcolm R. Alison,Stephanie Schier,Nicholas A. Wright.Bone Marrow Stem Cell–Mediated Regeneration in IBD: Where Do We Go From Here?[J].Gastroenterology.2007(3)
  • 8Stephen B. Hanauer,William J. Sandborn,Paul Rutgeerts,Richard N. Fedorak,Milan Lukas,Donald MacIntosh,Remo Panaccione,Douglas Wolf,Paul Pollack.Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial[J].Gastroenterology.2006(2)
  • 9D.DURAI,A. B.HAWTHORNE.Review article: how and when to use ciclosporin in ulcerative colitis[J].Alimentary Pharmacology & Therapeutics.2005(10)
  • 10Eaden,Abrams,Ekbom,Jackson,Mayberry.Colorectal cancer prevention in ulcerative colitis: a case‐control study[J].Aliment Pharmacol Ther.2001(2)

二级参考文献81

共引文献20

同被引文献32

  • 1Ajuebor MN, Hogaboam CM, Kunkel SL, et at. The che- mokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat [ J]. J Immunol, 2001, 166 ( 1 ) :552-558.
  • 2Kucuk C, Sozuer E, Gursoy S, et al. Treatment with Met- RANTES decreases bacterial translocation in experimental colitis[J]. Am J Surg, 2006, 191(1): 77-83.
  • 3Tokuyama H, Ueha S, Kurachi M, et at. The simuhane- ous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis [J]. Int Immunol, 2005, 17 (8):1023-1034.
  • 4Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, et at. Chemokine receptor homo- or heterodimerization activates distinct signaling pathways [ J ]. EMBO J, 2001, 20 (10) :2497-2507.
  • 5Sasaki S, Baba T, Shinagawa K, et at. Crucial involve- ment of the CCL3-CCR5 axis-mediated fibroblast accumu- lation in colitis-associated carcinogenesis in mice [ J ]. Int J Cancer,2014, 135(1) :1-10.
  • 6Ganju RK, Dutt P, Lijun Wu,et al. [3-Chemokine receptor CCR5 signals via the novel tyrosine kinase RAPTK [ J ]. Blood, 1998, 91 (3) :791-797.
  • 7Chuang JY, Yang WH, Chen HT, et al. CCLS/CCR5 axis promotes the motility of human oraleancer cells[ J]. J Cell Physiol, 2009, 220 ( 2 ) :418-426.
  • 8Wong M, Uddin S, Majchrzak B, et al. RANTES activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells [ J]J Biol Chem, 2001, 276 (14) : 11427-11431.
  • 9Fromowitz FB, Viola MV, Chao S, et al. Ras p21 expres- sion in the progression of breast cancer [ J 1. Hum Pathol, 1987, 18(12) :1268-1275.
  • 10Van Damme N, De Keyser F, Demetter P, et al. The pro- portion of Thl cells, which prevail in gut mucosa, is de- creased in inflammatory bowel syndrome [ J ] Clin Exp Im- munol, 2001, 125 (3) :383-390.

引证文献3

二级引证文献20

中华临床医师杂志（电子版）
2013年 第16期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部